OrthoPediatrics KIDS Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net revenue by Product | |||||
| Scoliosis | $66.05M+19.8% | $55.15M+45.4% | $37.93M+13.5% | $33.43M+19.2% | |
| Sports medicine/other | $4M-10.1% | $4.45M+10.7% | $4.02M+5.6% | $3.81M-8.8% | |
| Trauma and deformity | $166.3M+14.6% | $145.13M+35.9% | $106.78M+25.5% | $85.06M+29.2% | |
| Cost of revenue by Product | |||||
| Shipping and Handling, Billed | $1.54M+11.0% | $1.39M+11.3% | $1.24M+21.1% | $1.03M+27.9% | |
| Shipping and Handling, Not Billed | $7.52M+10.1% | $6.83M+20.7% | $5.66M+32.4% | $4.27M+47.3% | |
| Net revenue by Geography | |||||
| International | $49.95M+14.6% | $43.57M+15.5% | $37.72M+26.3% | $29.87M+47.4% | |
| U.S. | $186.4M+15.7% | $161.16M+45.2% | $111.01M+20.1% | $92.42M+18.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does OrthoPediatrics break its business down?
- OrthoPediatrics (KIDS) reports net revenue by product across 3 parts — Scoliosis, Sports medicine/other and Trauma and deformity. Each is extracted from the segment footnotes and tracked over time.
- Where does OrthoPediatrics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in OrthoPediatrics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
